StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > In case you forgot..

<< Previous

Bullboard Posts

Next >>

Comment by SAGDollaron Dec 01, 2020 3:11pm

160 Views

Post# 32011346

RE:RE:In case you forgot..

Deadornot wrote: We're all well aware of the success this company is having with COVID testing. Will not bash them for that. I just feel as though we're still in the dark about potentially the best product of the last 10 years

The silence intrigues me. I look forward to the flood gates opening. I look at Sona and the run it took over sweet f a. We have institutional investors that have invested millions and I'm sure they wouldn't if they weren't confident in SZLS' patented Sentinel Principle and Aristotle.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China